How To Establish An Effective Good Clinical Practice in Drugs and Medical Devices

This 90-minute webinar will help you establish an effective Good Clinical Practice (GCP) by providing a current, accurate and complete (CAC) review and understanding of the relevant and applicable regulations for clinical trials or studies, the requirements and compliance in a systematic, integrative (SI) manner.

Why Should You Attend:

To be able to achieve sustainability and to remain sustainable and competitive in global medical product markets, it is necessary to streamline regulatory compliance processes, in particular, the Good Clinical Practice (GCP) for clinical trials and studies and beyond. To establish and maintain GCP, it is critical to accurately define, document and implement “current, accurate, and complete” (CAC) requirements pursuant to the relevant and applicable laws and regulations, GCP requirements, and compliance in a systematic, integrative (SI) manner.

Areas Covered in the Seminar:

• Current, accurate, and complete (CAC) review of FDA regulations including INDs and IDEs.
• Systematic and integrative (SI) analysis of regulations and law governing clinical trials and studies, requirements, and compliance.
• General information for clinical studies.
• Clinical investigators (CI).
• Institutional review boards (IRBs).
• Sponsors.
• Monitors.
• Contract research organizations (CROs).
• ICH-GCP guidelines.
• ISO 14155.
• Enforcement actions (case studies).

Who will Benefit:

This webinar will be valuable for anyone in global medical industry including, but not limited to, those working on drugs, biologics, medical devices, and in vitro diagnostic devices who are involved in the processes of clinical trials and studies, adverse event reporting, complaint handling and regulatory compliance. By understanding Good Clinical Practice (GCP) for the clinical trials and studies in a systematic, integrative manner, the process owners can better establish and maintain the compliant processes, improving patient rights, safety, wellfare and further achieving regulatory compliance.

The following employees who will benefit include:

• Clinical affairs (associates, specialists, coordinators, managers, directors and VPs)
• Complaint handling personnel
• Regulatory affairs (associates, specialists, managers, and directors)
• Quality assurance, quality control, and quality systems (associates, specialists, engineers, managers, directors and VPs)
• Research and development (associates, scientists, managers, directors and VPs)
• Product and development (associates, scientists, managers, directors and VPs)
• Marketing (associates, specialists, managers, directors and VPs)
• Site managers, and consultants.
• Contract manufacturing organization (associates, scientists, managers, directors and VPs)
• Contract research organization (associates, scientists, managers, directors and VPs)
• Senior and executive management (VPs, SVPs, Presidents and CEOs)
• Contractors and subcontractors